Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAY.L Regulatory News (CAY)

  • There is currently no data for CAY

Interim Management Statement

28 Jul 2009 07:00

RNS Number : 3605W
Charles Stanley Group PLC
28 July 2009
 



INTERIM MANAGEMENT STATEMENT

QUARTER ENDED 30 JUNE 2009

As the Chairman will advise shareholders at today's Annual General Meeting, Charles Stanley Group PLC is pleased to announce that its revenue for the three months to 30 June 2009, the first quarter of its financial year 2009-10, was 2.4% higher, at £26.0 million, than the comparable figure of £25.4 million for the three months to 30 June 2008

Since 31 March 2009 the business has performed solidly in markets that continue to be challenging. Income has been resilient across all three divisions and we have strengthened the securities division with a number of new hires.

Total client funds under investment management or administration rose during the quarter by 10.0% from £9.0 billion at 31 March 2009 to £9.9 billion at 30 June 2009. Within this figure the funds under discretionary management increased by 11.1% from £2.7 billion to £3.0 billion. For the same period, the FTSE 100 strengthened by 8.3% from 3926 to 4249 and the FTSE APCIMS Balanced Portfolio Index by 3.9%.

It is difficult to predict how much longer the current conditions will prevail. However, with a strong balance sheet Charles Stanley is well placed to take advantage of further acquisition opportunities.

Quarter ended 30 June 2009

Private Clients

 £'000

Financial Services

£'000

Charles Stanley Securities

£'000

Total

 

£'000

Commission

11,893

8

2,206

14,107

Fees

Investment Management

5,108

51

-

5,159

Administration

4,035

2,123

-

6,158

Corporate Finance

-

-

543

543

Other

-

-

-

71

Total

21,036

2,182

2,749

26,038

 

30 June 2009

31 March 2009

Change

£bn

£bn

%

Discretionary funds under management

3.0

2.7

11.1%

Advisory funds under management

2.0

1.9

5.3%

Total funds under management 

5.0

4.6

8.7%

Advisory dealing funds

2.1

2.0

5.0%

Execution only funds

2.8

2.4

16.7%

Total administered funds

4.9

4.4

11.4%

Total funds under management and administration

9.9

9.0

10.0%

For further information please contact

Charles Stanley Group PLC Canaccord Adams Ltd

Peter Hurst, Director  Simon Bridges

Michael Lilwall, Director Phone: 020 7050 6500

Magnus Wheatley, Head of Press & Public Relations Oriel Securities Ltd

Phone: 020 7149 6273 Tom Durie

Email: magnus.wheatley@charles-stanley.co.uk Phone: 020 7710 7600

Notes for editors

Charles Stanley Group PLC has four trading companies, Charles Stanley & Co. Limited, EBS Management plc, Griffiths & Armour (Financial Services) Limited and Garrison Investment Analysis Limited. 

Charles Stanley & Co. Limited provides full-service stockbroking, financial planning and benefit consultancy and small and mid cap advisory and institutional broking. 

EBS Management plc provides specialist pensions administration services.

Griffiths & Armour (Financial Services) Limited is a specialist provider of corporate employee benefits services.

Garrison Investment Analysis Limited markets unit trusts, open-ended investment company units and packaged financial products to private clients, both directly and in wrappers such as ISAs and pensions.

All four trading companies are regulated by the Financial Services Authority. The Group has 32 offices around the United Kingdom.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZGGZNVNLGLZM
Date   Source Headline
6th May 20152:00 pmRNSProposed Sale of Charles Stanley Securities
27th Apr 201512:45 pmRNSHolding(s) in Company
20th Apr 20153:30 pmRNSProposed Sale of Charles Stanley Fin Sols
20th Apr 201511:27 amRNSDirector/PDMR Shareholding -Replacement
20th Apr 201510:55 amRNSDirector/PDMR Shareholding
20th Apr 201510:49 amRNSHolding(s) in Company
20th Apr 201510:45 amRNSDirector/PDMR Shareholding
20th Apr 201510:42 amRNSTotal Voting Rights
17th Apr 20154:31 pmRNSHolding(s) in Company
15th Apr 20154:22 pmRNSCompletion of Placing
15th Apr 20157:00 amRNSPre-close Trading Update & Placing to raise £15.8m
13th Apr 20151:28 pmRNSHolding(s) in Company
10th Apr 20154:29 pmRNSBlocklisting Interim Review
1st Apr 20156:19 pmRNSHolding(s) in Company
23rd Mar 20152:34 pmRNSDirector/PDMR Shareholding
19th Mar 201511:32 amRNSDirectorate Change
17th Mar 20151:53 pmRNSHolding in Company
10th Mar 20154:12 pmRNSDirector/PDMR Shareholding
10th Mar 201510:59 amRNSStatement re. Press Comment
30th Jan 20157:30 amRNSTotal Voting Rights
30th Jan 20157:00 amRNSInterim Management Statement
19th Jan 20157:30 amRNSBlock Listing Application
14th Jan 201511:21 amRNSHolding(s) in Company
12th Jan 20154:02 pmRNSDirector/PDMR Shareholding
12th Jan 20157:30 amRNSAdditional Listing
9th Jan 20159:49 amRNSDirectorate Change
30th Dec 20147:30 amRNSTotal Voting Rights
29th Dec 20147:30 amRNSAdditional Listing
24th Dec 201411:56 amRNSDirector/PDMR Shareholding
22nd Dec 201410:44 amRNSDirector/PDMR Shareholding
19th Dec 201410:45 amRNSDirectorate Change
9th Dec 20144:00 pmRNSHolding(s) in Company
3rd Dec 201412:19 pmRNSDirector/PDMR Shareholding
28th Nov 20143:50 pmRNSTotal Voting Rights
27th Nov 20147:00 amRNSHalf Yearly Report
4th Nov 201411:19 amRNSHolding(s) in Company
3rd Nov 20147:30 amRNSAdditional Listing
31st Oct 20144:27 pmRNSHolding(s) in Company
30th Oct 20149:37 amRNSTotal Voting Rights
27th Oct 20143:55 pmRNSHolding(s) in Company
27th Oct 20149:24 amRNSDirectorate Change
24th Oct 201412:49 pmRNSHolding(s) in Company
20th Oct 20147:30 amRNSAdditional Listing
9th Oct 201410:29 amRNSBlocklisting Interim Review
3rd Oct 20142:32 pmRNSHolding(s) in Company
25th Sep 201410:38 amRNSChange of CEO
8th Sep 20147:00 amRNSTrading Update
1st Sep 20149:27 amRNSTotal Voting Rights
19th Aug 201410:33 amRNSHolding(s) in Company
11th Aug 201410:05 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.